YTHDF2 Knockout Cell Line (A549)

-Methyladenosine (mA) is the most abundant internal RNA modification catalyzed by host RNA methyltransferases. As obligate intracellular parasites, many viruses acquire mA methylation in their RNAs. However, the biological functions of viral mA methylation are poorly understood. Here, we found that viral mA methylation serves as a molecular marker for host innate immunity to discriminate self from nonself RNA and that this novel biological function of viral mA methylation is universally conserved in several families in nonsegmented negative-sense (NNS) RNA viruses. Using mA methyltransferase (METTL3) knockout cells, we produced mA-deficient virion RNAs from the representative members of the families , , and and found that these mA-deficient viral RNAs triggered significantly higher levels of type I interferon compared to the mA-sufficient viral RNAs, in a RIG-I-dependent manner. Reconstitution of the RIG-I pathway revealed that mA-deficient virion RNA induced higher expression of RIG-I, bound to RIG-I more efficiently, enhanced RIG-I ubiquitination, and facilitated RIG-I conformational rearrangement and oligomerization. Furthermore, the mA binding protein YTHDF2 is essential for suppression of the type I interferon signaling pathway, including by virion RNA. Collectively, our results suggest that several families in NNS RNA viruses acquire mA in viral RNA as a common strategy to evade host innate immunity. The nonsegmented negative-sense (NNS) RNA viruses share many common replication and gene expression strategies. There are no vaccines or antiviral drugs for many of these viruses. We found that representative members of the families , , and among the NNS RNA viruses acquire mA methylation in their genome and antigenome as a means to escape recognition by host innate immunity via a RIG-I-dependent signaling pathway. Viral RNA lacking mA methylation induces a significantly higher type I interferon response than mA-sufficient viral RNA. In addition to uncovering mA methylation as a common mechanism for many NNS RNA viruses to evade host innate immunity, this study discovered a novel strategy to enhance type I interferon responses, which may have important applications in vaccine development, as robust innate immunity will likely promote the subsequent adaptive immunity.